查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1708220

CBD 营养保健品市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

CBD Nutraceuticals Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 131 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球 CBD 营养保健品市场规模达 107 亿美元，预估 2025 年至 2034 年期间复合年增长率将达到 17.5%。这一令人印象深刻的成长主要得益于人们越来越意识到大麻二酚 (CBD) 在管理慢性病和促进整体健康方面的益处。随着越来越多的消费者将注意力转向植物性、清洁标籤和健康产品，对 CBD 营养保健品的需求持续增长。消费者正在寻求传统药物的天然替代品，导致人们对基于 CBD 的补充剂的兴趣激增，这些补充剂具有抗炎、镇痛和缓解压力的功效，而且没有成瘾风险。此外，人工智慧 (AI) 驱动的个人化工具的进步透过指导产品选择和提供客製化建议显着增强了客户体验。

CBD 营养保健品市场 - IMG1

除此之外，该行业正在经历向永续、有机 CBD 种植实践的重大转变，从而产生更高效、更具成本效益的提取方法，使新旧参与者都受益。人们对环保生产方法的倾向日益增强，为品牌创造了机会，使其能够在保持高品质标准的同时满足具有环保意识的消费者的需求。此外，有利的监管框架（尤其是在美国等主要市场）正在鼓励进一步投资并推动 CBD 营养保健品领域的创新。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 107亿美元
预测值 531亿美元
复合年增长率 17.5%

市场分为几个产品类别，包括 CBD 油、酊剂、胶囊、软胶囊、软糖和其他形式。 CBD 油已成为最受欢迎的细分市场，2023 年的市值为 30 亿美元。这些油以其高吸收率和易于使用而闻名，可有效缓解慢性疼痛、压力和焦虑。 CBD 油透过舌下给药，作用迅速、有效，是寻求快速起效和持久效果的个人的首选。这些油具有各种浓度，可满足广泛的消费者偏好和治疗需求，使其成为市场上用途最广泛的产品之一。

CBD 营养保健品的应用涵盖疼痛管理、睡眠障碍、心理健康、减轻压力和其他健康问题。疼痛管理领域占据市场主导地位，到 2024 年将占据 35.5% 的显着份额，这主要是由于关节炎、纤维肌痛和偏头痛等慢性疼痛疾病的盛行率不断上升。 CBD 已被证实具有抗发炎和镇痛特性，使其成为比传统止痛药更安全、更有效的替代品，而传统止痛药通常会带来不良的副作用。由于 CBD 不具成瘾性且能够提供持续缓解，医疗保健提供者和患者都越来越多地选择它。

预计到 2034 年，美国 CBD 营养保健品市场将创造 257 亿美元的产值，在 2025 年至 2034 年期间保持 17.5% 的强劲复合年增长率。作为全球最大的 CBD 营养保健品市场，美国受益于有利的法规、较高的消费者认知度以及大麻衍生产品日益增长的接受度。关节炎、焦虑症和睡眠障碍等慢性病发病率的不断上升，进一步刺激了该地区对基于 CBD 的营养保健品的需求。不断变化的监管环境和对 CBD 治疗潜力的持续研究预计将推动持续成长，使美国市场处于全球 CBD 营养保健品产业的前沿。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 慢性病和精神健康障碍盛行率上升
      • 对植物性和天然补充剂的需求不断增长
      • 产品开发和配方的创新
    • 产业陷阱与挑战
      • CBD提取和产品开发成本高
      • 消费者对 CBD 的教育有限且有误解
  • 成长潜力分析
  • 监管格局
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：依产品类型，2021-2034

  • 主要趋势
  • CBD油
  • CBD酊剂
  • CBD胶囊和软胶囊
  • CBD软糖和咀嚼片
  • 其他产品类型

第六章：市场估计与预测：按应用，2021-2034

  • 主要趋势
  • 疼痛管理
  • 减轻焦虑和压力
  • 睡眠障碍
  • 心理健康
  • 其他应用

第七章：市场估计与预测：按配销通路，2021-2034 年

  • 主要趋势
  • 零售店
  • 药局
  • 电子商务
  • 其他分销管道

第八章：市场估计与预测：按地区，2021-2034

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • Bluebird Botanicals
  • Charlotte's Web
  • CV Sciences
  • Diamond CBD
  • Elixinol
  • ENDOCA
  • Foria Wellness
  • Garden of Life (Nestle)
  • Green Roads
  • Irwin Naturals
  • Isodiol
  • Medical Marijuana
  • MEDTERRA
简介目录
Product Code: 13355

The Global CBD Nutraceuticals Market generated USD 10.7 billion in 2024 and is expected to grow at a remarkable CAGR of 17.5% from 2025 to 2034. This impressive growth is primarily driven by the increasing awareness of the health benefits of cannabidiol (CBD) in managing chronic conditions and promoting overall wellness. As more consumers shift their focus toward plant-based, clean-label, and health-enhancing products, the demand for CBD nutraceuticals continues to gain momentum. Consumers are seeking natural alternatives to traditional medications, leading to a surge in interest in CBD-based supplements that offer anti-inflammatory, analgesic, and stress-relief properties without the risk of addiction. Furthermore, advancements in personalization tools powered by artificial intelligence (AI) have significantly enhanced customer experiences by guiding product choices and offering tailored recommendations.

CBD Nutraceuticals Market - IMG1

Alongside this, the industry is witnessing a major transition toward sustainable, organic CBD farming practices, resulting in more efficient and cost-effective extraction methods that are benefiting both new and established players. The rising inclination toward eco-friendly production methods is creating opportunities for brands to cater to environmentally conscious consumers while maintaining high-quality standards. Additionally, favorable regulatory frameworks, particularly in key markets such as the United States, are encouraging further investments and driving innovation in the CBD nutraceuticals space.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$10.7 Billion
Forecast Value$53.1 Billion
CAGR17.5%

The market is segmented into several product categories, including CBD oils, tinctures, capsules, soft gels, gummies, and other forms. CBD oils have emerged as the most popular segment, generating USD 3 billion in 2023. These oils, known for their high absorption rate and ease of use, provide effective relief from chronic pain, stress, and anxiety. Administered sublingually, CBD oils act quickly and efficiently, making them a preferred choice for individuals seeking fast-acting and long-lasting effects. Available in various concentrations, these oils cater to a wide range of consumer preferences and therapeutic needs, making them one of the most versatile products in the market.

The application of CBD nutraceuticals spans across pain management, sleep disorders, mental health, stress reduction, and other health concerns. The pain management segment dominated the market with a significant share of 35.5% in 2024, driven by the increasing prevalence of chronic pain conditions such as arthritis, fibromyalgia, and migraines. CBD's proven anti-inflammatory and analgesic properties have positioned it as a safer and more effective alternative to traditional pain medications, which often come with undesirable side effects. Both healthcare providers and patients are increasingly opting for CBD due to its non-addictive nature and ability to provide sustained relief.

The U.S. CBD nutraceuticals market is projected to generate USD 25.7 billion by 2034, maintaining a robust CAGR of 17.5% from 2025 to 2034. As the largest market for CBD nutraceuticals globally, the U.S. benefits from favorable regulations, high consumer awareness, and increasing acceptance of cannabis-derived products. The growing incidence of chronic conditions, including arthritis, anxiety, and sleep disorders, has further fueled the demand for CBD-based nutraceuticals in the region. The evolving regulatory landscape and ongoing research into the therapeutic potential of CBD are expected to drive sustained growth, positioning the U.S. market at the forefront of the global CBD nutraceuticals industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic diseases and mental health disorders
      • 3.2.1.2 Growing demand for plant-based and natural supplements
      • 3.2.1.3 Innovations in product development and formulations
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High costs of CBD extraction and product development
      • 3.2.2.2 Limited consumer education and misconceptions about CBD
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021-2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 CBD oils
  • 5.3 CBD tinctures
  • 5.4 CBD capsules and softgels
  • 5.5 CBD gummies and chews
  • 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pain management
  • 6.3 Anxiety and stress reduction
  • 6.4 Sleep disorders
  • 6.5 Mental health
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021-2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Retail stores
  • 7.3 Pharmacies
  • 7.4 E-commerce
  • 7.5 Other distribution channels

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Bluebird Botanicals
  • 9.2 Charlotte's Web
  • 9.3 CV Sciences
  • 9.4 Diamond CBD
  • 9.5 Elixinol
  • 9.6 ENDOCA
  • 9.7 Foria Wellness
  • 9.8 Garden of Life (Nestle)
  • 9.9 Green Roads
  • 9.10 Irwin Naturals
  • 9.11 Isodiol
  • 9.12 Medical Marijuana
  • 9.13 MEDTERRA